3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Breast Cancer -

X-ray doesn’t raise cancer risk in BRCA carriers

Breast CancerMar 22, 06

Exposure to the among of radiation produced by mammography does not substantially increase the risk of breast cancer in women with BRCA1 and BRCA2 gene mutations, even when screening begins at an early age, investigators report in The Lancet Oncology, published online on March 22.

Because BRCA mutations disrupt the repair of DNA damage, it was feared that DNA-damaging radiation from mammography would increase these patients’ risk.

Dr. Steven A. Narod, from the University of Toronto in Ontario, Canada, and colleagues in North America, Europe and Israel conducted a study with 1,600 patients diagnosed with breast cancer between 1952 and 2005, and another 1,600 women with the same age, BRCA mutation status and country of residence. There was no difference in the family histories of women in either group.

Before the calendar year in which the breast cancer patients were diagnosed, 41 percent of women with cancer and 46 percent of the comparison groups had at least one screening mammogram.

The two groups were similar in age at their first mammography (average age 35.3 years for breast cancer patients cases and 35.5 years for the comparison group). Thirteen percent of women with breast cancer had their first mammogram before 30 years of age versus 15 percent in the comparison group.

Narod and his team conclude that there is no association between screening mammography and risk of breast cancer in BRCA1/2 mutation carriers. However, more “studies are needed to confirm the results of this initial report,” they write, “and where possible, these studies should assess a more appropriate endpoint of total exposure.”

SOURCE: The Lancet Oncology, March 22, 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Fat grafting technique improves results of breast augmentation
  UW research shows sensor technology may help improve accuracy of clinical breast exams
  Generic Breast Cancer Drugs Boost Adherence
  New models of drug-resistant breast cancer point to better treatments
  Breast tomosynthesis increases cancer detection and reduces recall rates
  2 views are better than 1 in 3-D breast screening
  Study reveals genomic similarities between breast cancer and ovarian cancers
  Moderate exercise tied to lower breast cancer risk
  Risk for some cancers rises with U.S. obesity rate
  New genomic test spares patients chemotherapy with no adverse effect on survival
  Breast Cancer In Black Women Is A Different Disease
  Combination of Everolimus and Exemestane Improves Progression-Free Survival for Women with Metastatic Breast Cancer

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site